Manzil Healthcare Services partners with LifeSense Group to fight Incontinence

United Arab Emirates,16 January 2020: Manzil Healthcare Services, the leading digital healthcare service provider in the UAE, has partnered with Netherland-based technology development company LifeSense Group, to provide innovative health solutions to treat urinary incontinence in the Middle East.

“Denigma  Program” for urine incontinence treatments, developed by Manzil Healthcare, combines functional therapies and educational courses along with a personalized care approach to provide better care for patients while reducing complications and expensive hospital resources.

Manzil Healthcare, in collaboration with LifeSense Group, is looking to provide relief to the patients suffering from incontinence through the wearable system technology that effectively cures, monitors and prevents urine loss.

Urinary incontinence is a growing health concern among women across the Middle East. According to a recent study, over 40% of women in the UAE and 41% of women in the KSA suffer from this condition.

Dr. Sarper Tanli, Group CEO of Manzil Healthcare Services, said: “We remain committed to providing high quality, technology-enabled, multidisciplinary care to our patients in the comfort of their environment. Our collaboration with LifeSense is a testament to that commitment. We are very positive about this collaborative effort towards providing relief to individuals and families suffering from urinary incontinence.”

LifeSense Group is a technology development company that designs and creates applications for medical, health and wellbeing. It is transforming innovations into reality with its patented technology in smart textile, wearable technologies and mobile applications. 

Founded in the UAE, Manzil Healthcare, has expanded its reach to Qatar, Egypt, Saudi Arabia and Kuwait with disease management programs. The year 2020 is expected to be the year of growth and expansion for Manzil in Saudi Arabia with regards to medical home services, digital health and disease management. Manzil's foray into South East Asia is also underway.